BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31069822)

  • 21. Maternal and neonatal plasma microRNA biomarkers for fetal alcohol exposure in an ovine model.
    Balaraman S; Lunde ER; Sawant O; Cudd TA; Washburn SE; Miranda RC
    Alcohol Clin Exp Res; 2014 May; 38(5):1390-400. PubMed ID: 24588274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal smoking does not affect the amount of cell-free fetal DNA in maternal plasma during the 1st trimester of pregnancy.
    Tarquini F; Picchiassi E; Centra M; Pennacchi L; Galeone F; Bini V; Di Renzo GC; Coata G
    J Obstet Gynaecol; 2015 Jan; 35(1):42-5. PubMed ID: 24988452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of noninvasive prenatal testing for common fetal aneuploidies in an early gestational window.
    Shi X; Zhang Z; Cram DS; Liu C
    Clin Chim Acta; 2015 Jan; 439():24-8. PubMed ID: 25286007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First trimester maternal serum pregnancy-associated plasma protein A and pregnancy-specific beta 1-glycoprotein in fetal trisomies.
    Bersinger NA; Brizot ML; Johnson A; Snijders RJ; Abbott J; Schneider H; Nicolaides KH
    Br J Obstet Gynaecol; 1994 Nov; 101(11):970-4. PubMed ID: 7528054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of maternal smoking on concentrations of the pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of chorionic gonadotropin (beta hCG) in the first trimester of pregnancy].
    Gajewska J; Ceran A; Chełchowska M; Borowski D; Ambroszkiewicz J; Jaczyńska R; Zwoliński J; Laskowska-Klita T
    Przegl Lek; 2008; 65(10):479-82. PubMed ID: 19189527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies.
    Ong CY; Lee CP; Leung KY; Lau E; Tang MH
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular vesicle-enriched miRNA profiles across pregnancy in the MADRES cohort.
    Foley HB; Howe CG; Eckel SP; Chavez T; Gevorkian L; Reyes EG; Kapanke B; Martinez D; Xue S; Suglia SF; Bastain TM; Marsit C; Breton CV
    PLoS One; 2021; 16(5):e0251259. PubMed ID: 33979365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine trophoblast-derived and pregnancy-associated exosome-enriched extracellular vesicle microRNAs: Implications for placenta driven effects on maternal physiology.
    Stefanski AL; Martinez N; Peterson LK; Callahan TJ; Treacy E; Luck M; Friend SF; Hermesch A; Maltepe E; Phang T; Dragone LL; Winn VD
    PLoS One; 2019; 14(2):e0210675. PubMed ID: 30730971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Various levels of circulating exosomal total-miRNA and miR-210 hypoxamiR in different forms of pregnancy hypertension.
    Biró O; Alasztics B; Molvarec A; Joó J; Nagy B; Rigó J
    Pregnancy Hypertens; 2017 Oct; 10():207-212. PubMed ID: 29153681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Termination of pregnancy due to fetal central nervous system abnormalities performed after 24 weeks' gestation: survey of 57 fetuses from a single medical center.
    Melcer Y; Maymon R; Krajden Haratz K; Goldrat I; Shavit M; Ben-Ami I; Vaknin Z
    Arch Gynecol Obstet; 2018 Sep; 298(3):551-559. PubMed ID: 29959513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First trimester noninvasive fetal RHD genotyping using maternal dried blood spots.
    Xiong Y; Jeronis S; Hoffman B; Liebermann DA; Geifman-Holtzman O
    Prenat Diagn; 2017 Apr; 37(4):311-317. PubMed ID: 28081297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiological and regulatory roles of activin A in late pregnancy.
    Jenkin G; Ward J; Loose J; Schneider-Kolsky M; Young R; Canny B; O'Connor A; de Kretser D; Wallace E
    Mol Cell Endocrinol; 2001 Jun; 180(1-2):131-8. PubMed ID: 11451582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Turning the pyramid of prenatal care.
    Nicolaides KH
    Fetal Diagn Ther; 2011; 29(3):183-96. PubMed ID: 21389681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K; Bindra R; Cacho AM; Nicolaides KH
    Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic characterization of macro-, micro- and nano-extracellular vesicles derived from the same first trimester placenta: relevance for feto-maternal communication.
    Tong M; Kleffmann T; Pradhan S; Johansson CL; DeSousa J; Stone PR; James JL; Chen Q; Chamley LW
    Hum Reprod; 2016 Apr; 31(4):687-99. PubMed ID: 26839151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Noninvasive prenatal test in the first trimester of pregnancy (NT and estimation of beta-hCG and PAPP-A) in the diagnosis of fetal abnormalities in Polish population--comparison of the biochemistry own normal ranges and literature reported data].
    Mandryka-Stankewycz S; Perenc M; Dec G; Sieroszewski P
    Ginekol Pol; 2009 Nov; 80(11):851-5. PubMed ID: 20088400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNAs as clinical biomarkers in the predictions of pregnancy complications.
    Tsochandaridis M; Nasca L; Toga C; Levy-Mozziconacci A
    Biomed Res Int; 2015; 2015():294954. PubMed ID: 25699269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Indications for genetic amniocentesis investigated at the Department of Gynecology, Obstetrics, and Oncologic Gynecology, Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz].
    Sadłecki P; Walentowicz-Sadłecka M; Pasińska M; Adamczak R; Grabiec M
    Ginekol Pol; 2014 Jun; 85(6):420-3. PubMed ID: 25029805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.